ArticleIranian journal of basic medical sciences2026
Neuroprotective effect of selenium in rats subjected to chronic intermittent cold and immobilization stress: The role of phosphorylated tau.
Article in Iranian journal of basic medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The current study aimed to investigate the potential neuroprotective effect of selenium against cognitive dysfunction in rats subjected to chronic intermittent stress. Materials and Methods: Ninety adult male Wistar rats were randomly assigned into five groups (n=18): (1) N: non-stressed group; (2) CS: cold-stressed non-treated group; (3) IS: immobilized-stressed non-treated group; (4) CS/Se: cold-stressed/ selenium-treated group; and (5) IS/Se: immobilized-stressed/selenium-treated group. Memory and learning were assessed using the Morris Water Maze, novel object recognition, and Y-maze tests. After completion of neurobehavioral tests, fasting retro-orbital blood samples were collected from all rats. Stress hormones, serum sodium and potassium, oxidative stress markers (malondialdehyde (MDA), total antioxidant capacity (TAC), glutathione peroxidase (GPx), and thioredoxin reductase (TrxR)), and the proinflammatory markers (tumor necrosis factor-alpha (TNF-α), intercellular adhesion molecule-1 (ICAM-1)) were measured. Histopathological examination of the hippocampus and immunohistochemistry of p-tau were performed. Results: The results indicated that memory and learning were impaired by chronic intermittent stress. This was associated with histopathological changes of the hippocampus and increased the expression of p-tau. Selenium administration improved the cognitive dysfunction as indicated by behavioral tests. Also, it reduced the levels of stress hormones, sodium, MDA, and the proinflammatory markers. It significantly enhanced the antioxidant enzyme activities and increased the potassium level. In addition, it improved the histopathological changes of the hippocampus and decreased the expression of p-tau. Conclusion: Coadministration of selenium to rats subjected to chronic stress improved cognitive dysfunction by its antioxidant and anti-inflammatory effects, as well as via downr-egulation of p-tau in the hippocampus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.